showed a trendP = 0.09
IL-6 showed a trend towards an increase in prolactinoma patients (1.1 [IQR 0.6–1.5] pg/ml in cases vs. 0.6 [IQR 0.5–1.0] pg/ml in controls, P = 0.09).
IL-6 showed a trend towards an increase in prolactinoma patients (1.1 [IQR 0.6–1.5] pg/ml in cases vs. 0.6 [IQR 0.5–1.0] pg/ml in controls, P = 0.09).